About this episode
Drugs like Ozempic and Wegovy have skyrocketed in popularity over the past few years. To capitalize on that demand, telehealth companies started offering compounded versions of those drugs. That’s made them easier to access, but it’s also introduced new potential risks for people recovering from eating disorders like anorexia.
On today’s Big Take podcast, Bloomberg reporter Madison Muller joins host Sarah Holder to share what she’s learned about the ways telehealth can make it easier for people to get prescriptions that could harm them.
Read more: The Weight-Loss Drug Gold Rush Has a Dangerous Prescription Problem
See omnystudio.com/listener for privacy information.
Get every episode summarized
Each time Big Take publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Big Take
So Could AI 'Kill Us All'?
Big Take
Trump Needs a Win. Enter His Venezuela Oil Deal
Big Take
Why the Bond Market Has Everyone On Edge
Big Take
Americans Are Spending Billions to Help Their Pets Live Longer
Big Take